As discussed by Dell'Italia et al. [21], [22], [50], non-ACE formation of Ang II is known to maintain plasma and cardiac Ang II concentrations in heart failure subjects treated with adequate doses of ACE inhibitors. The gene discussed is ACE; the disease is heart failure.